OOIR: Observatory of International Research

Papers

(The TQCC of Annals of Neurology is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
COVID‐19: A Global Threat to the Nervous System	352
Disease‐Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis	349
Steroid‐Responsive Encephalitis in Coronavirus Disease 2019	189
Guillain‐Barré Syndrome following ChAdOx1‐S/nCoV‐19 Vaccine	149
ANA Investigates: Neurological Complications of COVID‐19 Vaccines	143
Prevention of Epilepsy in Infants with Tuberous Sclerosis Complex in the EPISTOP Trial	142
Safety and Efficacy of Omaveloxolone in Friedreich Ataxia (MOXIe Study)	138
Guillain–Barré Syndrome Variant Occurring after SARS‐CoV‐2 Vaccination	132
Role of B Cells in Multiple Sclerosis and Related Disorders	129
Clinical Features and Risk of Relapse in Children and Adults with Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease	126
Gut Microbiome in Progressive Multiple Sclerosis	116
COVID‐19 Vaccine Response in People with Multiple Sclerosis	111
Gut Microbial Ecosystem in Parkinson Disease: New Clinicobiological Insights from Multi‐Omics	102
COVID‐19 Vaccine‐Associated Cerebral Venous Thrombosis in Germany	102
Radiologically Isolated Syndrome: 10‐Year Risk Estimate of a Clinical Event	100
The Impact of SARS‐CoV‐2 on Stroke Epidemiology and Care: A Meta‐Analysis	98
Aerobic Exercise Alters Brain Function and Structure in Parkinson's Disease: A Randomized Controlled Trial	96
Paramagnetic Rim Lesions are Specific to Multiple Sclerosis: An International Multicenter 3T MRI Study	91
Longitudinal Assessment of Multiple Sclerosis with the Brain‐Age Paradigm	86
Postvaccinal Encephalitis after ChAdOx1 nCov‐19	85
Ultra‐Early Blood Pressure Reduction Attenuates Hematoma Growth and Improves Outcome in Intracerebral Hemorrhage	85
Remote Blood Biomarkers of Longitudinal Cognitive Outcomes in a Population Study	83
Causal Associations Between Modifiable Risk Factors and the Alzheimer's Phenome	83
Neurological Events Reported after COVID‐19 Vaccines: An Analysis of Vaccine Adverse Event Reporting System	78
Alpha‐Synuclein Oligomers and Neurofilament Light Chain in Spinal Fluid Differentiate Multiple System Atrophy from Lewy Body Synucleinopathies	78

Diagnostic Utility of Gold Coast Criteria in Amyotrophic Lateral Sclerosis	77
Serum Glial Fibrillary Acidic Protein: A Neuromyelitis Optica Spectrum Disorder Biomarker	76
Incidence, clinical, risk factors and outcomes of Guillain‐Barré in Covid‐19	76
Nilotinib Effects on Safety, Tolerability, and Biomarkers in Alzheimer's Disease	75
Speech Biomarkers in Rapid Eye Movement Sleep Behavior Disorder and Parkinson Disease	73
Preservation of Brain Activity in Unresponsive Patients Identifies MCS Star	72
Pediatric Ischemic Stroke: An Infrequent Complication of SARS‐CoV‐2	70
Loss‐of‐Function Variants in HOPS Complex Genes VPS16 and VPS41 Cause Early Onset Dystonia Associated with Lysosomal Abnormalities	69
Temporal Lobe Epilepsy Surgical Outcomes Can Be Inferred Based on Structural Connectome Hubs: A Machine Learning Study	69
Identifying Progression in Multiple Sclerosis: New Perspectives	68
Real‐World Effectiveness of Initial Disease‐Modifying Therapies in Pediatric Multiple Sclerosis	68
Serum Neurofilament Light Chain Levels in the Intensive Care Unit: Comparison between Severely Ill Patients with and without Coronavirus Disease 2019	67
Probabilistic Mapping of Deep Brain Stimulation: Insights from 15 Years of Therapy	67
Multisystem Involvement in Post‐Acute Sequelae of Coronavirus Disease 19	67
Anti‐migraine Calcitonin Gene–Related Peptide Receptor Antagonists Worsen Cerebral Ischemic Outcome in Mice	66
Effects of IgLON5 Antibodies on Neuronal Cytoskeleton: A Link between Autoimmunity and Neurodegeneration	64
Inflammatory Cytokine Patterns Associated with Neurological Diseases in Coronavirus Disease 2019	64
SARS‐CoV‐2 and Mitochondrial Proteins in Neural‐Derived Exosomes of COVID‐19	63
Sex Mediates Relationships Between Regional Tau Pathology and Cognitive Decline	62
Association of Plasma Neurofilament Light with Postoperative Delirium	62
Blood–Brain Barrier Breakdown in Relationship to Alzheimer and Vascular Disease	61
An Overview of Monkeypox Virus and Its Neuroinvasive Potential	60
Amylin Analog Pramlintide Induces Migraine‐like Attacks in Patients	59
Brain Insulin Signaling, Alzheimer Disease Pathology, and Cognitive Function	59
DBS of Thalamic Centromedian Nucleus for Lennox–Gastaut Syndrome (ESTEL Trial)	59
Noninvasive Characterization of Human Glymphatics and Meningeal Lymphatics in an in vivo Model of Blood–Brain Barrier Leakage	58
Prior Anticoagulation in Patients with Ischemic Stroke and Atrial Fibrillation	58
COVID‐19–Associated Encephalopathy and Cytokine‐Mediated Neuroinflammation	56
Long‐Term Safety and Efficacy of Eculizumab in Aquaporin‐4 IgG‐Positive NMOSD	55
Seizures after Ischemic Stroke: A Matched Multicenter Study	55
Alpha‐Synuclein Oligomers and Neurofilament Light Chain Predict Phenoconversion of Pure Autonomic Failure	54
Keratinocytes Communicate with Sensory Neurons via Synaptic‐like Contacts	54
Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease	54
Dopaminergic Retinal Cell Loss and Visual Dysfunction in Parkinson Disease	54
NOTCH2NLC Intermediate‐Length Repeat Expansions Are Associated with Parkinson Disease	53
Circulating Lipoprotein Lipids, Apolipoproteins and Ischemic Stroke	53
Regional Brain Growth Trajectories in Fetuses with Congenital Heart Disease	53
Report on Electroencephalographic Findings in Critically Ill Patients with COVID‐19	52
Clinico‐Genetic, Imaging and Molecular Delineation of COQ8A‐Ataxia: A Multicenter Study of 59 Patients	52
Subthalamic Nucleus Deep Brain Stimulation Modulates 2 Distinct Neurocircuits	52
Magnetic Resonance Images Implicate That Glymphatic Alterations Mediate Cognitive Dysfunction in Alzheimer Disease	51
Targeting Inflammasomes to Treat Neurological Diseases	51
Non‐Motor Symptoms in Parkinson's Disease are Reduced by Nabilone	51
A Pilot Randomized, Controlled, Double‐Blind Trial of Bumetanide to Treat Neonatal Seizures	50
Characterizing the Genetic Architecture of Parkinson's Disease in Latinos	50
Meningeal CGRP‐Prolactin Interaction Evokes Female‐Specific Migraine Behavior	49
Parkinson Disease and Subthalamic Nucleus Deep Brain Stimulation: Cognitive Effects in GBA Mutation Carriers	49
The New Normal in Clinical Trials: Decentralized Studies	48
MRI in Neuromuscular Diseases: An Emerging Diagnostic Tool and Biomarker for Prognosis and Efficacy	48
Bridging Therapy or IV Thrombolysis in Minor Stroke with Large Vessel Occlusion	48

Long‐Term Cognitive Outcome in Anti–N‐Methyl‐D‐Aspartate Receptor Encephalitis	47
Optic Disc Classification by Deep Learning versus Expert Neuro‐Ophthalmologists	47
Induction of Human Motor Cortex Plasticity by Theta Burst Transcranial Ultrasound Stimulation	47
Intact Brain Network Function in an Unresponsive Patient with COVID‐19	46
Comparative Effectiveness of Stereotactic Electroencephalography Versus Subdural Grids in Epilepsy Surgery	46
SCN3A‐Related Neurodevelopmental Disorder: A Spectrum of Epilepsy and Brain Malformation	46
The CSF Profile Linked to Cortical Damage Predicts Multiple Sclerosis Activity	46
Retracted: Gut Microbiome Signatures of Risk and Prodromal Markers of Parkinson Disease	45
Characterization of Recessive Parkinson Disease in a Large Multicenter Study	44
Lewy Body–like Inclusions in Human Midbrain Organoids Carrying Glucocerebrosidase and α‐Synuclein Mutations	44
SARS‐CoV‐2 and Multiple Sclerosis: Not All Immune Depleting DMTs are Equal or Bad	43
Electroencephalographic Abnormalities are Common in COVID‐19 and are Associated with Outcomes	43
Lesion Age Imaging in Acute Stroke: Water Uptake in CT Versus DWI‐FLAIR Mismatch	43
Pediatric Leigh Syndrome: Neuroimaging Features and Genetic Correlations	43
Spinal Cord Atrophy Predicts Progressive Disease in Relapsing Multiple Sclerosis	43
Plasma p‐tau231, p‐tau181, PET Biomarkers, and Cognitive Change in Older Adults	43
A Stearoyl–Coenzyme A Desaturase Inhibitor Prevents Multiple Parkinson Disease Phenotypes in α‐Synuclein Mice	43
Biallelic Intronic AAGGG Expansion of RFC1 is Related to Multiple System Atrophy	43
Optogenetic Spreading Depression Elicits Trigeminal Pain and Anxiety Behavior	42
Adaptive Platform Trials to Transform Amyotrophic Lateral Sclerosis Therapy Development	41
Socioeconomic Status Mediates Racial Differences Seen Using the AT(N) Framework	41
Antibodies Contributing to Focal Epilepsy Signs and Symptoms Score	41
Predictors of Long‐Term Outcome of Subthalamic Stimulation in Parkinson Disease	41
Gut Microbiome Signatures of Risk and Prodromal Markers of Parkinson Disease	41
Development and Validation of Forecasting Next Reported Seizure Using e‐Diaries	41
Increasing Brain Gamma Activity Improves Episodic Memory and Restores Cholinergic Dysfunction in Alzheimer's Disease	40
Lower Lymphocyte Count is Associated With Increased Risk of Parkinson's Disease	40
Axon‐Myelin Unit Blistering as Early Event in MS Normal Appearing White Matter	40
Retinal Thickness Predicts the Risk of Cognitive Decline in Parkinson Disease	40
7T MRI Differentiates Remyelinated from Demyelinated Multiple Sclerosis Lesions	40
Transcranial Magnetic Stimulation Promotes Gait Training in Parkinson Disease	40
NOTCH2NLC GGC Repeat Expansions Are Associated with Sporadic Essential Tremor: Variable Disease Expressivity on Long‐Term Follow‐up	38
Superficial Siderosis: A Clinical Review	38
Intact HIV Proviruses Persist in the Brain Despite Viral Suppression with ART	38
Selective Endothelial Hyperactivation of Oncogenic KRAS Induces Brain Arteriovenous Malformations in Mice	37
Early‐Onset Parkinsonism Is a Manifestation of the PPP2R5D p.E200K Mutation	37
Apolipoprotein E4 Reduction with Antisense Oligonucleotides Decreases Neurodegeneration in a Tauopathy Model	37
Detection of Brain Somatic Mutations in Cerebrospinal Fluid from Refractory Epilepsy Patients	37
Hypersensitivity to Calcitonin Gene–Related Peptide in Post‐Traumatic Headache	36
Heritability Enrichment Implicates Microglia in Parkinson's Disease Pathogenesis	36
Neuroinflammation and Tau Colocalize in vivo in Progressive Supranuclear Palsy	36
EIF2AK2 Missense Variants Associated with Early Onset Generalized Dystonia	35
Neuropathological Variability within a Spectrum of NMDAR‐Encephalitis	35
Intrinsic and Extrinsic Mechanisms of Thalamic Pathology in Multiple Sclerosis	35
Covert Speech Comprehension Predicts Recovery From Acute Unresponsive States	34
Association between Pregnancy and Cervical Artery Dissection	34
Foslevodopa/Foscarbidopa: A New Subcutaneous Treatment for Parkinson's Disease	34
Genetically Elevated LDL Associates with Lower Risk of Intracerebral Hemorrhage	34
Clinical Variability in Spinal Muscular Atrophy Type III	34
Complement Activation Is a Prominent Feature of MOGAD	34
Mechanisms of Ischemic Stroke in Patients with Cancer: A Prospective Study	34
Diagnostic Accuracy of Amyloid versus ¹⁸F‐Fluorodeoxyglucose Positron Emission Tomography in Autopsy‐Confirmed Dementia	33
Alzheimer‐Related Cerebrovascular Disease in Down Syndrome	33
Genome‐Wide Association Study Identifies Risk Loci for Cluster Headache	33
Very Low Residual Dystrophin Quantity Is Associated with Milder Dystrophinopathy	33
Silent New Brain MRI Lesions in Children with MOG‐Antibody Associated Disease	32
Adoptive Transfer of JC Virus‐Specific T Lymphocytes for the Treatment of Progressive Multifocal Leukoencephalopathy	32
Adults with Cerebral Palsy Require Ongoing Neurologic Care: A Systematic Review	31
NMDAR Antibodies Alter Dopamine Receptors and Cause Psychotic Behavior in Mice	31
NIA‐AA Alzheimer's Disease Framework: Clinical Characterization of Stages	31
A New Advanced MRI Biomarker for Remyelinated Lesions in Multiple Sclerosis	31
Normal Pressure Hydrocephalus Associated with Alzheimer's Disease	31
Menopause Status Moderates Sex Differences in Tau Burden: A Framingham PET Study	31
Ravulizumab in Aquaporin‐4–Positive Neuromyelitis Optica Spectrum Disorder	31
Sleep Disruption in Epilepsy: Ictal and Interictal Epileptic Activity Matter	31
Sensitivity–Specificity of Tau and Amyloid β Positron Emission Tomography in Frontotemporal Lobar Degeneration	31
Investigation of Autosomal Genetic Sex Differences in Parkinson's Disease	30
Cerebrospinal Fluid Analysis Post–COVID‐19 Is Not Suggestive of Persistent Central Nervous System Infection	30
Contributors to Serum NfL Levels in People without Neurologic Disease	30
Risk Factors for Phenoconversion in Rapid Eye Movement Sleep Behavior Disorder	30
Leucine Zipper 4 Autoantibody: A Novel Germ Cell Tumor and Paraneoplastic Biomarker	30
Subtype Diagnosis of Sporadic Creutzfeldt–Jakob Disease with Diffusion Magnetic Resonance Imaging	30
Dimethyl Fumarate Delays Multiple Sclerosis in Radiologically Isolated Syndrome	29
Scalp Ripples Can Predict Development of Epilepsy After First Unprovoked Seizure in Childhood	29
Genomewide Association Studies of LRRK2 Modifiers of Parkinson's Disease	29
Encephalitis with Autoantibodies against the Glutamate Kainate Receptors GluK2	29
B Cell Depletion and SARS‐CoV‐2 Vaccine Responses in Neuroimmunologic Patients	29
Noninvasive Mapping of Ripple Onset Predicts Outcome in Epilepsy Surgery	29
Blood Metal Levels and Amyotrophic Lateral Sclerosis Risk: A Prospective Cohort	29
Glycine Receptor Autoantibodies Impair Receptor Function and Induce Motor Dysfunction	28

A Prodromal Brain‐Clinical Pattern of Cognition in Synucleinopathies	28
Validation of the Neurogenic Orthostatic Hypotension Ratio with Active Standing	28
Subthalamic Nucleus Stimulation Modulates Motor Epileptic Activity in Humans	28
Genetic Risk of Alzheimer's Disease and Sleep Duration in Non‐Demented Elders	28
Association between Migraine and Cryptogenic Ischemic Stroke in Young Adults	28
Subicular Caspase‐1 Contributes to Pharmacoresistance in Temporal Lobe Epilepsy	28
Perfusion Imaging and Clinical Outcome in Acute Ischemic Stroke with Large Core	27
Leucine‐Rich Glioma‐Inactivated 1 versus Contactin‐Associated Protein‐like 2 Antibody Neuropathic Pain: Clinical and Biological Comparisons	27
Common X‐Chromosome Variants Are Associated with Parkinson Disease Risk	27
Longitudinal Changes in Hippocampal Network Connectivity in Alzheimer's Disease	27
Decreased Frontal Gamma Activity in Alzheimer Disease Patients	27
Tuber Locations Associated with Infantile Spasms Map to a Common Brain Network	26
Clinical and Magnetic Resonance Imaging Outcome Predictors in Pediatric Anti–N‐Methyl‐D‐Aspartate Receptor Encephalitis	26
Circulating Metabolites Differentiate Acute Ischemic Stroke from Stroke Mimics	26
Genetic Susceptibility Loci in Genomewide Association Study of Cluster Headache	26
Staufen1 in Human Neurodegeneration	25
Single Photon Emission Computed Tomography/Positron Emission Tomography Molecular Imaging for Parkinsonism: A Fast‐Developing Field	25
Brain Structure and Degeneration Staging in Friedreich Ataxia: Magnetic Resonance Imaging Volumetrics from the ENIGMA‐Ataxia Working Group	25
Perfusion Imaging Predicts Favorable Outcomes after Basilar Artery Thrombectomy	25
Comparison of Core Features in Four Developmental Encephalopathies in the Rett Natural History Study	25
Deep Brain Stimulation for Chronic Cluster Headache: Meta‐Analysis of Individual Patient Data	24
Non–Cell Autonomous Epileptogenesis in Focal Cortical Dysplasia	24
Salivary CGRP and Erenumab Treatment Response: Towards Precision Medicine in Migraine	24
Prediction Model of Amyotrophic Lateral Sclerosis by Deep Learning with Patient Induced Pluripotent Stem Cells	24
The Distinct Traits of the UNC13A Polymorphism in Amyotrophic Lateral Sclerosis	24
Implantable Cardiac Monitoring in the Secondary Prevention of Cryptogenic Stroke	24
Postictal Death Is Associated with Tonic Phase Apnea in a Mouse Model of Sudden Unexpected Death in Epilepsy	24
Multicenter Validation of the max‐ICH Score in Intracerebral Hemorrhage	24
Personalizing Deep Brain Stimulation Using Advanced Imaging Sequences	24
Severe Acute Respiratory Syndrome Coronavirus 2 Third Vaccine Immune Response in Multiple Sclerosis Patients Treated with Ocrelizumab	24
Plasma NT1 Tau is a Specific and Early Marker of Alzheimer's Disease	24
Reply to the Letter “COVID‐19‐Associated Encephalopathy and Cytokine‐Mediated Neuroinflammation”	23
Characterization of the Insular Role in Cardiac Function through Intracranial Electrical Stimulation of the Human Insula	23
Different Cortical Gyrification Patterns in Alzheimer's Disease and Impact on Memory Performance	23
Circulating microRNAs Associated With Reversible Cerebral Vasoconstriction Syndrome	23
Bornavirus Encephalitis Shows a Characteristic Magnetic Resonance Phenotype in Humans	23
Sorbitol Is a Severity Biomarker for PMM2‐CDG with Therapeutic Implications	23
Anticoagulation Timing in Cardioembolic Stroke and Recurrent Event Risk	22
Hippocampal Shape Is Associated with Memory Deficits in Temporal Lobe Epilepsy	22
Changing Gears – DBS For Dopaminergic Desensitization in Parkinson's Disease?	22
Iron Heterogeneity in Early Active Multiple Sclerosis Lesions	22
Dysregulation of the Retromer Complex System in Down Syndrome	22
GGPS1 Mutations Cause Muscular Dystrophy/Hearing Loss/Ovarian Insufficiency Syndrome	22
Subthalamic and Pallidal Stimulations in Patients with Parkinson's Disease: Common and Dissociable Connections	22
Premortem Chronic Traumatic Encephalopathy Diagnoses in Professional Football	22
Tau‐Atrophy Variability Reveals Phenotypic Heterogeneity in Alzheimer's Disease	22
Hydroxychloroquine for Primary Progressive Multiple Sclerosis	22
Parkinson's Disease Derived Exosomes Aggravate Neuropathology in SNCA*A53T Mice	22
α‐Synuclein Seed Amplification in CSF and Brain from Patients with Different Brain Distributions of Pathological α‐Synuclein in the Context of Co‐Pathology and Non‐LBD Diagnoses	22
Longitudinal Development of Peripapillary Hyper‐Reflective Ovoid Masslike Structures Suggests a Novel Pathological Pathway in Multiple Sclerosis	22
Childhood Neurotoxicity and Brain Resilience to Adverse Events during Adulthood	22
Targeted tDCS Mitigates Dual‐Task Costs to Gait and Balance in Older Adults	21
Management of Cerebral Venous Thrombosis Due to Adenoviral COVID‐19 Vaccination	21
A Novel Multisystem Proteinopathy Caused by a Missense ANXA11 Variant	21
Stratifying the Presymptomatic Phase of Genetic Frontotemporal Dementia by Serum NfL and pNfH: A Longitudinal Multicentre Study	21
Mapping the Insula with Stereo‐Electroencephalography: The Emergence of Semiology in Insula Lobe Seizures	21
Permeability Measures Predict Hemorrhagic Transformation after Ischemic Stroke	21
Regional Precuneus Cortical Hyperexcitability in Alzheimer's Disease Patients	21
CAG Repeat Size Influences the Progression Rate of Spinocerebellar Ataxia Type 3	21
Multimodal Biomarkers Quantify Recovery in Autoimmune Autonomic Ganglionopathy	21
Cerebral Cortical Encephalitis in Myelin Oligodendrocyte Glycoprotein Antibody‐Associated Disease	21
Progressive Multifocal Leukoencephalopathy Treated by Immune Checkpoint Inhibitors	21
Microglial Activation and Connectivity in Alzheimer Disease and Aging	21
“Ependymal‐in” Gradient of Thalamic Damage in Progressive Multiple Sclerosis	21
Deep Brain Stimulation for Arm Tremor: A Randomized Trial Comparing Two Targets	21
Location and Size of Preterm Cerebellar Hemorrhage and Childhood Development	21
Cortical Correlates of Gait Compensation Strategies in Parkinson Disease	21
Automated Annotation of Epileptiform Burden and Its Association with Outcomes	20
Cellular and Humoral Immunity to SARS‐CoV‐2 Infection in Multiple Sclerosis Patients on Ocrelizumab and Other Disease‐Modifying Therapies: A Multi‐Ethnic Observational Study	20
The Optimal Target and Connectivity for Deep Brain Stimulation in Lennox–Gastaut Syndrome	20
MRI Clustering Reveals Three ALS Subtypes With Unique Neurodegeneration Patterns	20
Frailty and Risk of Dementia in Mild Cognitive Impairment Subtypes	20
Perfusion‐Dependent Cerebral Autoregulation Impairment in Hemispheric Stroke	20
Advances in Treatment of Progressive Multifocal Leukoencephalopathy	20
Rest‐Activity Pattern Alterations in Idiopathic REM Sleep Behavior Disorder	20
Vision Therapy: Ocular Motor Training in Mild Traumatic Brain Injury	20
Longitudinal Retinal Changes in MOGAD	20
A Subpopulation of Spikes Predicts Successful Epilepsy Surgery Outcome	20
Magnetic Resonance Imaging Evaluation of Perivascular Space Abnormalities in Neuromyelitis Optica	19
Cytokines in New‐Onset Refractory Status Epilepticus Predict Outcomes	19
Anti‐Neuronal Nuclear Antibody 3 Autoimmunity Targets Dachshund Homolog 1	19
Human Brain Resilience: A Call to Action	19
T_max Volumes Predict Final Infarct Size and Functional Outcome in Ischemic Stroke Patients Receiving Endovascular Treatment	19
147th Annual Meeting American Neurological Association	19
Proinflammatory CD20⁺ T Cells are Differentially Affected by Multiple Sclerosis Therapeutics	19
Lewy Body Disease is a Contributor to Logopenic Progressive Aphasia Phenotype	19
Faster Cortical Thinning and Surface Area Loss in Presymptomatic and Symptomatic C9orf72 Repeat Expansion Adult Carriers	19
Synaptic Loss in Multiple Sclerosis Spinal Cord	19
ZSCAN1 Autoantibodies Are Associated with Pediatric Paraneoplastic ROHHAD	19
Guillain‐Barré Syndrome in an Australian State Using Both mRNA and Adenovirus‐Vector SARS‐CoV‐2 Vaccines	19
CD8⁺ T‐Lymphocyte–Driven Limbic Encephalitis Results in Temporal Lobe Epilepsy	19
GIPC1 CGG Repeat Expansion Is Associated with Movement Disorders	18
Natural History of Leigh Syndrome: A Study of Disease Burden and Progression	18
Probabilistic Mapping Reveals Optimal Stimulation Site in Essential Tremor	18
Human CASPR2 Antibodies Reversibly Alter Memory and the CASPR2 Protein Complex	18